Sirolimus-coated balloon shows 8-percentage-point advantage in three-year peripheral artery trial
Patients treated with sirolimus-coated balloons were more likely to remain free from repeat procedures to reopen blocked leg arteries than those receiving paclitaxel-coated balloons, according to three-year results from the SIRONA clinical trial presented at TCT 2026. While both treatments showed similar improvements in walking ability and quality of life,…
The Economic Times ·